Literature DB >> 9607942

Current perspectives on pain upon injection of drugs.

G A Brazeau1, B Cooper, K A Svetic, C L Smith, P Gupta.   

Abstract

A limitation in the administration of parenteral products is the pain caused upon injection. Injection site pain has been predominately associated with intravenous, intramuscular, and subcutaneous administration. It becomes important for the formulation scientist to have a basic understanding of the physiology underlying the pain process, as well as the pharmaceutical factors associated with injection site pain. Initially, this review will provide the reader with a primer on the mediation of pain in the periphery and a compilation of those drugs that have been associated with pain on injection. In addition, this review will present important considerations and general formulation approaches or methods that have been used to overcome pain on injection. Finally, a brief overview of the various experimental systems used to investigate injection site pain is discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9607942     DOI: 10.1021/js970315l

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  18 in total

Review 1.  Solubilizing excipients in oral and injectable formulations.

Authors:  Robert G Strickley
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

2.  Composition optimization and stability testing of a parenteral antifungal solution based on a ternary solvent system.

Authors:  Kristóf Kovács; István Antal; György Stampf; Imre Klebovich; Krisztina Ludányi
Journal:  AAPS PharmSciTech       Date:  2010-02-24       Impact factor: 3.246

Review 3.  Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.

Authors:  Annette Bak; Dennis Leung; Stephanie E Barrett; Seth Forster; Ellen C Minnihan; Andrew W Leithead; James Cunningham; Nathalie Toussaint; Louis S Crocker
Journal:  AAPS J       Date:  2014-11-15       Impact factor: 4.009

4.  Subcutaneous Injection Site Pain of Formulation Matrices.

Authors:  Galen H Shi; Karthik Pisupati; Jonathan G Parker; Vincent J Corvari; Christopher D Payne; Wen Xu; David S Collins; Michael R De Felippis
Journal:  Pharm Res       Date:  2021-05-03       Impact factor: 4.200

5.  Acute changes in muscle blood flow and concomitant muscle damage after an intramuscular administration.

Authors:  Pierre Jean Ferré; Eckart Thein; Isabelle Raymond-Letron; Pierre-Louis Toutain; Hervé Pierre Lefebvre
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

6.  Emulsifiers' composition modulates venous irritation of the nanoemulsions as a lipophilic and venous irritant drug delivery system.

Authors:  Chengwen Mao; Jiangling Wan; Huabing Chen; Huibi Xu; Xiangliang Yang
Journal:  AAPS PharmSciTech       Date:  2009-08-11       Impact factor: 3.246

7.  Clinical factors affecting the pain on injection of propofol.

Authors:  Hye-Joo Kang; Mi-Young Kwon; Byoung-Moon Choi; Min-Seok Koo; Young-Jae Jang; Myoung-Ae Lee
Journal:  Korean J Anesthesiol       Date:  2010-03-29

Review 8.  [Intramuscular injections in children].

Authors:  C Hünseler; B Roth; R Pothmann; P Reinhold
Journal:  Schmerz       Date:  2005-04       Impact factor: 1.107

9.  Pain on injection with microemulsion propofol.

Authors:  Ji-Yeon Sim; Soo-Han Lee; Do-Yang Park; Jin-Ah Jung; Kyoung-Ho Ki; Dong-Ho Lee; Gyu-Jeong Noh
Journal:  Br J Clin Pharmacol       Date:  2008-12-10       Impact factor: 4.335

10.  Discomfort from an alkaline formulation delivered subcutaneously in humans: albumin at pH 7 versus pH 10.

Authors:  W Kenneth Ward; Jessica R Castle; Deborah L Branigan; Ryan G Massoud; Joseph El Youssef
Journal:  Clin Drug Investig       Date:  2012-07-01       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.